The Protective Effects of Borax on Doxorubicin Induced Cardiotoxicity In Rats
Abstract
Keywords
Supporting Institution
Project Number
Thanks
References
- Baker S.D., Pharm D. 1997. Drug interaction with the taxanes. Pharmacotherapy, 17: 126-132.
- Muggia F.M., Green M.D. 1991. New anthracycline antitumor antibiotics. Critical Reviews oncology/ Hematology, 11: 43-64.
- Hideg K., Kálai T. 2007. Novel antioxidants in anthracycline cardiotoxicity. Cardiovascular Toxicology, 7: 160-164.
- Ferrans V.J. 1983. Anthracycline cardiotoxicity. Advances in Experimental Medicine and Biology, 161: 519-532.
- Childs A.C., Phaneuf S.L., Dirks A.J., Phillips T., Leeuweburgh C. 2002. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity and Bcl2. Cancer Research, 62: 4592-4598.
- Menna P., Salvatorelli E., Minotti G. 2008. Cardiotoxicity of antitumor drugs. Chemical Research in Toxicology, 21: 978-989.
- Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Squadrito F., Altavilla D., Bitto A. 2017. Oxidative stress: harms and benefits for human health. Oxidative Medicine and Cellular Longevity, 8416763. doi: 10.1155/2017/8416763
- Zhang H., Davies K.J.A., Forman H.J. 2015. Oxidative stress response and Nrf2 signaling in aging. Free Radical Biology and Medicine, 88: 314-336.
Details
Primary Language
English
Subjects
-
Journal Section
Research Article
Authors
Gökhan Oto
0000-0002-8492-4846
Türkiye
Publication Date
September 17, 2021
Submission Date
March 9, 2021
Acceptance Date
June 3, 2021
Published in Issue
Year 2021 Volume: 10 Number: 3
Cited By
Borax pentahydrate as a promising boron-based angiogenesis inhibitor
Journal of Trace Elements in Medicine and Biology
https://doi.org/10.1016/j.jtemb.2025.127640